Elan Diamond, MD

Articles

Unmet Needs in the Management of Advanced RCC

June 22nd 2022

Drs Alter and Diamond muse about the unmet needs in advanced RCC treatment.

Cabozantinib + Nivolumab Regimen in the Treatment of Advanced RCC

June 22nd 2022

A discussion on the role of the cabozantinib and nivolumab regimen in the treatment of advanced RCC.

Patient Profile Presentation: A 56-Year-Old Man with Clear Cell RCC

June 16th 2022

Robert Alter, MD, presents the patient profile of a 56-year-old man with clear cell renal cell carcinoma presenting with hip and leg pain.

Advanced RCC Patient Referrals from Community Oncologists

June 16th 2022

Elan Diamond, MD, describes when and how often community oncologists refer patients with suspected advanced renal cell carcinoma to his practice.

Nivolumab + Ipilimumab Combination Regimen for Advanced RCC

June 8th 2022

Oncologists review the IO/IO combination regimens available for treatment of advanced RCC and discuss patient selection for treatment with nivolumab and ipilimumab.

Patient Profile Presentation: A 70-Year-Old Man with Stage 4 Clear Cell RCC

June 8th 2022

Dr Elan Diamond presents the patient profile of a 70-year-old man with stage IV clear cell renal cell carcinoma.

Sequencing Therapies for Advanced RCC

June 2nd 2022

Experts discuss how they sequence I/O–TKI treatments for advanced renal cell carcinoma.

Toxicities with IO-TKI Combination Regimens for Advanced RCC and Their Management

June 2nd 2022

Elan Diamond, MD, explains toxicities commonly seen with I/O–TKI combination regimens, how to manage them, and how to discuss toxicities with patients with advanced renal cell carcinoma.

Front-Line Lenvatinib + Pembrolizumab Combination Regimens for Advanced RCC: Selecting Patients and Dose

May 25th 2022

A review of the first-line I/O-TKI combination regimens available for advanced RCC and selecting the right patients and dose for treatment with lenvatinib and pembrolizumab.

Patient Profile Presentation: A 56-Year-Old Man with Metastatic Clear Cell RCC

May 25th 2022

Robert Alter, MD, presents the patient profile of a 56-year-old man with metastatic clear cell renal cell carcinoma presenting with chromaturia.